Ensituximab, CAS 1092658-06-4

Product Description: Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Richard D Kim, et al. Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer. Clin Cancer Res. 2020 Jul 15;26(14):3557-3564. /[2]Julian A Marin-Acevedo, et al. Cancer immunotherapy beyond immune checkpoint inhibitors. J Hematol Oncol. 2018 Jan 12;11(1):8.

CAS Number: 1092658-06-4

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99362-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99362-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK